Chemoinformaics analysis of 2-NAPHTHALEN-1-YLACETIC ACID
| Molecular Weight | 186.21 | nRot | 2 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 10 |
| Exact Molecular Weight | 186.068 | nRing | 2 |
| Solubility: LogS | -0.693 | nHRing | 0 |
| Solubility: LogP | -0.654 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 11 |
| nHA | 1 | APOL | 28.3119 |
| nHD | 1 | BPOL | 10.9001 |
| QED | 0.087 |
| Synth | 4.476 |
| Natural Product Likeliness | 1.479 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.003 |
| HIA | 0.985 |
| CACO-2 | -5.679 |
| MDCK | 0.0000345 |
| BBB | 0.222 |
| PPB | 0.776187 |
| VDSS | 0.472 |
| FU | 0.19692 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.04 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.88 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.139 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.003 |
| CL | 0.729 |
| T12 | 0.452 |
| hERG | 0.004 |
| Ames | 0.022 |
| ROA | 0.192 |
| SkinSen | 0.05 |
| Carcinogencity | 0.217 |
| EI | 0.009 |
| Respiratory | 0.875 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.638211 |